Stock Analysis

Adams Diversified Equity Fund (ADX): Evaluating Valuation After Latest Annual Distribution Announcement

Adams Diversified Equity Fund (ADX) has announced a distribution of $0.46 per share, with payment scheduled for December 23, 2025. This maintains their strong history of annual payouts for investors.

See our latest analysis for Adams Diversified Equity Fund.

ADX’s $0.46 distribution comes as the fund’s momentum remains firmly positive, with the latest share price at $23.17 and a 14.36% gain year-to-date. Impressively, long-term investors have seen a total return of 23.38% over the past year, and triple-digit returns over both the three- and five-year horizons. This signals resilient growth potential even as market sentiment evolves.

If you’re looking for fresh opportunities beyond steady income payers like ADX, consider expanding your search and discover fast growing stocks with high insider ownership

But are these impressive returns a sign that ADX is trading at a discount with room to run? Or has the market already factored in every ounce of its future growth, leaving little opportunity for new buyers?

Advertisement

Price-to-Earnings of 8x: Is it justified?

ADX is currently trading at a price-to-earnings ratio of just 8x, suggesting a significant discount compared to its peers and industry averages, relative to its $23.17 closing price.

The price-to-earnings (P/E) ratio compares a company’s share price to its earnings per share. This gives investors an idea of what the market is willing to pay for expected profits. For Adams Diversified Equity Fund, this relatively low P/E means investors are paying less for each dollar of earnings than they would for most similar funds.

With an 8x P/E, the market appears to be underpricing ADX’s recent performance. The peer average is 15x and the US Capital Markets industry average is 24x. If sentiment shifts or profitability stabilizes, there is scope for the valuation multiple to move closer to those sector norms.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 8x (UNDERVALUED)

However, shifting market sentiment or unexpected declines in fund earnings could quickly reverse ADX’s current momentum. This could introduce fresh uncertainty for investors.

Find out about the key risks to this Adams Diversified Equity Fund narrative.

Another View: Discounted Cash Flow Tells a Different Story

While ADX’s price-to-earnings ratio suggests undervaluation, our SWS DCF model paints an even starker picture. At $23.17 per share, ADX is trading about 49% below our estimate of its fair value ($45.26). Does this signal a true long-term bargain, or is something being missed in the numbers?

Look into how the SWS DCF model arrives at its fair value.

ADX Discounted Cash Flow as at Nov 2025
ADX Discounted Cash Flow as at Nov 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Adams Diversified Equity Fund for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 874 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Adams Diversified Equity Fund Narrative

If our analysis does not fully match your perspective or you value doing your own due diligence, you can build your own view from the available data in just a few minutes. Do it your way

A great starting point for your Adams Diversified Equity Fund research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.

Looking for more smart investment ideas?

Seize fresh opportunities today with the Simply Wall Street Screener. Open the door to unique stocks you may have missed and give your portfolio an edge.

  • Unlock the potential of companies at the intersection of medicine and technology by searching these 31 healthcare AI stocks to discover those set to transform healthcare with artificial intelligence.
  • Tap into strong recurring income streams by checking out these 16 dividend stocks with yields > 3%, which offers yields above 3 percent and robust financial strength.
  • Ride the momentum of breakthrough innovation by joining these 24 AI penny stocks to find leaders in the artificial intelligence revolution who are reshaping entire industries.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com